Association of programmed cell death 1 polymorphisms and systemic lupus erythematosus: a meta-analysis

Abstract

Programmed cell death 1 (PDCD1 or PD1) polymorphisms have been inconsistently reported to be associated with systemic lupus erythematosus (SLE). The aim of this study was to explore whether the PDCD1 polymorphisms confer a susceptibility to SLE and lupus nephritis (LN). We conducted a meta-analysis on the association of PDCD1 polymorphisms with SLE in overall and specific ethnic populations. A total of 15 separate comparisons were included in this meta-analysis consisting of nine Europeans, two Latin Americans, two Africans, one Asian and one unknown participant. In subgroup analysis, the PD1.3A allele was significantly associated with SLE in Latin Americans (OR = 3.073, 95% CI = 1.416–6.461, P = 0.003), but not in patients of European and African decent. The PD1.3A allele was a risk factor for LN in European descendants (OR = 2.207, 95% CI = 1.488–3.467, P < 0.001). The PD1.5C allele was a risk factor for SLE in Europeans (OR = 1.297, 95% CI = 1.024–1.643, P = 0.031). In conclusion, this meta-analysis demonstrated an association of the PD1.3A allele with LN in European and SLE in Latin-American populations. Furthermore, the PD1.5C allele was associated with SLE susceptibility in Europeans.

Keywords

meta-analysis PDCD1 polymorphisms systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

1 Harley JB Kelly JA Kaufman KM . Unraveling the genetics of systemic lupus erythematosus. Springer Semin Immunopathol 2006; 28: 119–130.

2 Okazaki T Wang J . PD-1/PD-L pathway and autoimmunity. Autoimmunity 2005; 38: 353–357.

3 Nishimura H Minato N Nakano T Honjo T . Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int Immunol 1998; 10: 1563–1572.

4 Lindqvist AK Steinsson K Johanneson B . A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q. J Autoimmun 2000; 14: 169–178.

5 Nishimura H Nose M Hiai H Minato N Honjo T . Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999; 11: 141–151.

6 Prokunina L Castillejo-Lopez C Oberg F . A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002; 32: 666–669.

7 Wang SC Chen YJ Ou TT . Programmed death-1 gene polymorphisms in patients with systemic lupus erythematosus in Taiwan. J Clin Immunol 2006; 26: 506–511.

8 Johansson M Arlestig L Moller B Rantapaa-Dahlqvist S . Association of a PDCD1 polymorphism with renal manifestations in systemic lupus erythematosus. Arthritis Rheum 2005; 52: 1665–1669.

9 Nielsen C Laustrup H Voss A Junker P Husby S Lillevang ST . A putative regulatory polymorphism in PD-1 is associated with nephropathy in a population-based cohort of systemic lupus erythematosus patients. Lupus 2004; 13: 510–516.

10.

10 Lin SC Yen JH Tsai JJ . Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus. Arthritis Rheum 2004; 50: 770–775.

11.

11 Prokunina L Gunnarsson I Sturfelt G . The systemic lupus erythematosus-associated PDCD1 polymorphism PD1.3A in lupus nephritis. Arthritis Rheum 2004; 50: 327–328.

12.

12 Ferreiros-Vidal I Gomez-Reino JJ Barros F . Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects. Arthritis Rheum 2004; 50: 2590–2597.

13.

13 Sanghera DK Manzi S Bontempo F Nestlerode C Kamboh MI . Role of an intronic polymorphism in the PDCD1 gene with the risk of sporadic systemic lupus erythematosus and the occurrence of antiphospholipid antibodies. Hum Genet 2004; 115: 393–398.

14.

14 Velazquez-Cruz R Orozco L Espinosa-Rosales F . Association of PDCD1 polymorphisms with childhood-onset systemic lupus erythematosus. Eur J Hum Genet 2007; 15: 336–341.

15.

15 Ferreiros-Vidal I D'Alfonso S Papasteriades C . Bias in association studies of systemic lupus erythematosus susceptibility due to geographical variation in the frequency of a programmed cell death 1 polymorphism across Europe. Genes Immun 2007; 8: 138–146.

16.

16 Thorburn CM Prokunina-Olsson L Sterba KA . Association of PDCD1 genetic variation with risk and clinical manifestations of systemic lupus erythematosus in a multiethnic cohort. Genes Immun 2007; 8: 279–287.

17.

17 Egger M Smith GD Phillips AN . Meta-analysis: principles and procedures. BMJ 1997; 315: 1533–1537.

18.

18 Egger M Davey SG Schneider M Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629–634.

19.

19 Duval S Tweedie R . Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 455–463.

20.

20 Davey SG Egger M . Meta-analyses of randomised controlled trials. Lancet 1997; 350: 1182.

21.

21 Higgins JP Thompson SG . Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539–1558.

22.

22 DerSimonian R Laird N . Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–188.

23.

23 Bonferroni CE . Il calcolo delle assicurazioni su gruppi di teste. In: Studi in Onore del Professore Salvatore Ortu Carboni [Italien]. Rome, Italy; 1935. p. 13–60.

24.

24 Krishnan S Chowdhury B Tsokos GC . Autoimmunity in systemic lupus erythematosus: integrating genes and biology. Semin Immunol 2006; 18: 230–243.